{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T02:01:40Z","timestamp":1694397700758},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T00:00:00Z","timestamp":1409097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40268-014-0061-9","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T05:06:49Z","timestamp":1409029609000},"page":"221-225","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Periodic Rosuvastatin or Atorvastatin Dosing Arrays (PRADA): Patient-Centered Practice"],"prefix":"10.1007","volume":"14","author":[{"given":"Theodore","family":"Christou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesham R.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,27]]},"reference":[{"issue":"22","key":"61_CR1","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/archinte.161.22.2685","volume":"161","author":"I Lemieux","year":"2001","unstructured":"Lemieux I, Lamarche B, Couillard C, et al. Total cholesterol\/HDL cholesterol ratio vs LDL cholesterol\/HDL cholesterol ratio as indices of ischemic heart disease risk in men: The Quebec Cardiovascular Study. Arch Intern Med. 2001;161(22):2685\u201392.","journal-title":"Arch Intern Med"},{"key":"61_CR2","doi-asserted-by":"crossref","unstructured":"The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med. 1998;339(19):1349\u201357.","DOI":"10.1056\/NEJM199811053391902"},{"issue":"9326","key":"61_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group","year":"2002","unstructured":"Heart Protection Study Collaborative Group. MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial. Lancet. 2002;360(9326):7\u201322.","journal-title":"Lancet"},{"issue":"6","key":"61_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, B\u00e9gaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study. Cardiovasc Drugs Ther. 2005;19(6):403\u201314.","journal-title":"Cardiovasc Drugs Ther"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","volume":"6","author":"JD Cohen","year":"2012","unstructured":"Cohen JD, et al. Understating statin use in America and gaps in patient education (USAGE): an internet-based survey of 10,138 current and former statin users. J Clin Lipidol. 2012;6:208\u201315.","journal-title":"J Clin Lipidol"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.288.4.462","volume":"288","author":"CA Jackevicius","year":"2003","unstructured":"Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2003;288:462\u20137.","journal-title":"JAMA"},{"issue":"2","key":"61_CR7","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.amjcard.2006.07.093","volume":"99","author":"BD Mackie","year":"2007","unstructured":"Mackie BD, Satija S, Nell C, Miller J 3rd, Sperling LS. Monday, Wednesday, and Friday dosing of rosuvastatin in patients previously intolerant to statin therapy. Am J Cardiol. 2007;99(2):291.","journal-title":"Am J Cardiol"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jacl.2011.03.454","volume":"5","author":"SP Kennedy","year":"2011","unstructured":"Kennedy SP, Barnas GP, Schmidt MJ, Glisczinski MS, Paniagua AC. Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance. J Clin Lipidol. 2011;5:308\u201315.","journal-title":"J Clin Lipidol"},{"issue":"2","key":"61_CR9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.amjmed.2012.08.007","volume":"126","author":"FI Marcus","year":"2013","unstructured":"Marcus FI, Baumgarten AJ, Fritz WL, Nolan PE. Alternate-day dosing with statins. Am J Med. 2013;126(2):99\u2013104.","journal-title":"Am J Med"},{"key":"61_CR10","first-page":"1055","volume":"40","author":"AD McCormick","year":"2000","unstructured":"McCormick AD, Butters CJ, Miles GS, Baba T, Touchi A, Yamaguchi Y. ZD4522-An HMG-CoA reductase inhibitor free of metabolically mediated drug interactions: metabolic studies in human in vitro systems. J Clin Pharmacol. 2000;40:1055.","journal-title":"J Clin Pharmacol"},{"issue":"11","key":"61_CR11","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/S0149-2918(03)80336-3","volume":"25","author":"PD Martin","year":"2003","unstructured":"Martin PD, Warwick MJ, Dane AL, Hill SJ, Giles PB, Phillips PJ, Lenz E. Metabolism, exceretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers. Clin Ther. 2003;25(11):2822\u201335.","journal-title":"Clin Ther"},{"key":"61_CR12","unstructured":"Atorvastatin (Lipitor): prices for 30 tablets of atorvastatin 20mg (generic). http:\/\/www.goodrx.com\/atorvastatin\/price . Accessed July 2014"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","volume":"288","author":"JS Benner","year":"2002","unstructured":"Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455\u201361.","journal-title":"JAMA"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/hrt.2003.026187","volume":"90","author":"AK Mantel-Teeuwisse","year":"2004","unstructured":"Mantel-Teeuwisse AK, Goettsch WG, Klungel OH, De Boer A, Herings RMC. Long term persistence with statin treatment in daily medical practice. Heart. 2004;90:1065\u20136.","journal-title":"Heart"}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-014-0061-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-014-0061-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-014-0061-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T13:12:31Z","timestamp":1551186751000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-014-0061-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,27]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s40268-014-0061-9","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,27]]}}}